CIBC Bancorp USA’s Medline MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$559K Buy
16,112
+1,084
+7% +$39.7K ﹤0.01% 1305
2026
Q2
$593K Buy
+15,028
New +$606K ﹤0.01% 1252

Other funds holding MDLN

CIBC Bancorp USA's MDLN Position: Q3 2026 in Review

CIBC Bancorp USA increased its Medline (MDLN) stake by 7.2% in Q3 2026, buying an estimated $39.7K and bringing the position to 16,112 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #1305.

CIBC Bancorp USA first reported a position in MDLN in Q2 2026 and has held it in 2 quarters since. The position peaked at $593K in Q2 2026. 415 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • CIBC Bancorp USA held 16,112 shares of Medline worth $559K as of Q3 2026.
  • CIBC Bancorp USA bought 1,084 Medline shares in Q3 2026, an estimated $39.7K.
  • Medline made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1305 holding.
  • CIBC Bancorp USA first reported a position in Medline in Q2 2026 and has held it in 2 quarters since.
  • CIBC Bancorp USA's Medline position peaked at $593K in Q2 2026.
  • 415 funds tracked by Wall St. Rank held Medline as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.